Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SNUH-CD19-CAR-T in Pediatric R/R B-ALL
NCT05210907Phase 1Recruiting
- Sponsor
- Seoul National University Hospital
- Start
- Feb 2022
- Primary completion
- Sep 2025
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of SNUH-CD19-CAR-T in B cell acute lymphoblastic leukemia (B-ALL), sponsored by Seoul National University Hospital. Primary endpoint: Incidence of adverse events and its severity at 12 months. Started Feb 2022; status: recruiting.
02
Drugs
SNUH-CD19-CAR-T
03
Conditions
B cell acute lymphoblastic leukemia (B-ALL)
Beyond the preview
Go deeper on NCT05210907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05210907.